Technical Analysis

In our Healthcare theme MET plays an important role. We are re-instating a buy rating @ $4.05 mark as this high quality stock is trading well below its NTA of $7.

1234

We recommend investors to ‘average in to’ stock buying strategy to manage volatility and price fluctuations.

We predict more price fluctuations in the coming weeks and Chart depicts $28 as a good entry support point and this will reduce downside risk. Averaging in is going to be a good buying strategy for our investors

1234

30-Mar-20

weekly 22 march

1

08-Mar-20